Dan Su
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
Papers in
- Oncology 35
- Cancer Immunotherapy and Biomarkers 11
- Lung Cancer Research Studies 10
- Cancer Cells and Metastasis 7
-
- Cancer Genomics and Diagnostics 8
- Co-authors
- Lisha Ying (23 shared papers)Weimin Mao (9 shared papers)Liming Sheng (4 shared papers)Jianguo Feng (4 shared papers)Herbert Yu (8 shared papers)Junzhou Wu (7 shared papers)Fanrong Zhang (8 shared papers)Kaiyan Chen (10 shared papers)
- Journals
- Nature Communications (6 papers)Oncotarget (5 papers)Cancer Letters (3 papers)Lung Cancer (2 papers)International Journal of Cancer (2 papers)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Dan Su
94 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 99
- Oncology 895
- Cancer Research 534
- Pulmonary and Respiratory Medicine 553
- Molecular Biology 855
- Reproductive Medicine 111
Countries citing papers authored by Dan Su
This map shows the geographic impact of Dan Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Su more than expected).
Fields of papers citing papers by Dan Su
This network shows the impact of papers produced by Dan Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Su. The network helps show where Dan Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Dan Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 119 | |
| 2 | 2019 | 119 | |
| 3 | 2019 | 113 | |
| 4 | 2021 | 108 | |
| 5 | 2007 | 103 | |
| 6 | 2014 | 99 | |
| 7 | 2013 | 95 | |
| 8 | 2016 | 95 | |
| 9 | 2007 | 88 | |
| 10 | 2014 | 87 | |
| 11 | 2021 | 84 | |
| 12 | 2017 | 77 | |
| 13 | 2017 | 74 | |
| 14 | 2019 | 74 | |
| 15 | 2020 | 71 | |
| 16 | 2013 | 70 | |
| 17 | 2009 | 65 | |
| 18 | 2021 | 64 | |
| 19 | 2021 | 64 | |
| 20 | 2016 | 63 |
About Dan Su
Dan Su is a scholar working on Oncology, Cancer Research, Reproductive Medicine, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 97 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Ovarian cancer diagnosis and treatment (10 papers), Lung Cancer Research Studies (10 papers), Esophageal Cancer Research and Treatment (10 papers), Lung Cancer Treatments and Mutations (8 papers), Cancer Genomics and Diagnostics (8 papers), Cancer Cells and Metastasis (7 papers) and Ubiquitin and proteasome pathways (5 papers). The work is most often cited by research in Oncology (895 citations), Cancer Research (534 citations), Pulmonary and Respiratory Medicine (553 citations), Molecular Biology (855 citations) and Reproductive Medicine (111 citations). Dan Su has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Lisha Ying, Weimin Mao, Liming Sheng, Jianguo Feng, Herbert Yu, Junzhou Wu, Fanrong Zhang, Kaiyan Chen, Zhihua Liu and Pengjun Zhao. Their work appears in journals such as Nature Communications, Oncotarget, Cancer Letters, Lung Cancer and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.